Literature DB >> 21225690

Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.

Chuancang Jiang1, Ming-Lang Zhao, Richard M Scearce, Marilyn Diaz.   

Abstract

OBJECTIVE: We previously generated MRL/lpr mice deficient in activation-induced deaminase (AID) that lack isotype switching and immunoglobulin hypermutation. These mice have high levels of unmutated (germline) autoreactive IgM, yet they experienced an increase in survival and an improvement in lupus nephritis that exceeded that of MRL/lpr mice lacking IgG. The purpose of the present study was to test the hypothesis that high levels of germline autoreactive IgM in these mice confer protection against lupus nephritis.
METHODS: Autoreactive IgM antibodies of various specificities, including antibodies against double-stranded DNA (dsDNA), from AID-deficient MRL/lpr mice were given to asymptomatic MRL/lpr mice, and the levels of cytokines, proteinuria, immune complex deposition in the kidneys, and glomerulonephritis were examined. Novel AID-deficient MRL/lpr mice that lack any antibodies were generated for comparison to AID-deficient MRL/lpr mice that secrete only IgM.
RESULTS: Treatment with IgM anti-dsDNA resulted in a dramatic improvement in lupus nephritis. Other autoreactive IgM antibodies, such as antiphospholipid and anti-Sm, did not alter the pathologic changes. Secretion of proinflammatory cytokines by macrophages and the levels of inflammatory cells and apoptotic debris in the kidneys were lower in mice receiving IgM anti-dsDNA. Protective IgM derived from AID-deficient MRL/lpr mice displayed a distinct B cell repertoire, with a bias toward members of the V(H) 7183 family.
CONCLUSION: IgM anti-dsDNA protected MRL/lpr mice from lupus nephritis, likely by stopping the inflammatory cascade leading to kidney damage. A distinct repertoire of V(H) usage in IgM anti-dsDNA hybridomas from AID-deficient mice suggests that there is enrichment of a dedicated B cell population that secretes unmutated protective IgM in these mice.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225690      PMCID: PMC3079514          DOI: 10.1002/art.30230

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  50 in total

1.  Unexpected autoantibody production in membrane Ig-mu-deficient/lpr mice.

Authors:  D Melamed; E Miri; N Leider; D Nemazee
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

Review 2.  Systemic lupus erythematosus, complement deficiency, and apoptosis.

Authors:  M C Pickering; M Botto; P R Taylor; P J Lachmann; M J Walport
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

3.  Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells.

Authors:  Paul K Potter; Josefina Cortes-Hernandez; Pierre Quartier; Marina Botto; Mark J Walport
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

Review 4.  The central role of dendritic cells and interferon-alpha in SLE.

Authors:  Virginia Pascual; Jacques Banchereau; A Karolina Palucka
Journal:  Curr Opin Rheumatol       Date:  2003-09       Impact factor: 5.006

5.  Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.

Authors:  F Förger; T Matthias; M Oppermann; H Becker; K Helmke
Journal:  Lupus       Date:  2004       Impact factor: 2.911

6.  Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency.

Authors:  Pierre Quartier; Jacinta Bustamante; Ozden Sanal; Alessandro Plebani; Marianne Debré; Anne Deville; Jiri Litzman; Jacov Levy; Jean-Paul Fermand; Peter Lane; Gerd Horneff; Guzide Aksu; Isik Yalçin; Graham Davies; Ilhan Tezcan; Furgen Ersoy; Nadia Catalan; Kohsuhe Imai; Alain Fischer; Anne Durandy
Journal:  Clin Immunol       Date:  2004-01       Impact factor: 3.969

Review 7.  Mediators of injury in lupus nephritis.

Authors:  Jim C Oates; Gary S Gilkeson
Journal:  Curr Opin Rheumatol       Date:  2002-09       Impact factor: 5.006

8.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

9.  Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern.

Authors:  Yijin Li; Hui Li; Dongyao Ni; Martin Weigert
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

10.  Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice.

Authors:  Zhiyan Liang; Chun Xie; Cui Chen; Desi Kreska; Kelvin Hsu; Liunan Li; Xin J Zhou; Chandra Mohan
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

View more
  29 in total

1.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Abrogated AID Function Prolongs Survival and Diminishes Renal Pathology in the BXSB Mouse Model of Systemic Lupus Erythematosus.

Authors:  Jing Zhu; Alayna N Hay; Ashley A Potter; Madison W Richwine; Thomas Sproule; Tanya LeRoith; John Wilson; Muneer G Hasham; Derry C Roopenian; Caroline M Leeth
Journal:  J Immunol       Date:  2020-01-27       Impact factor: 5.422

3.  Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE.

Authors:  Thiago Detanico; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Autoimmun       Date:  2015-01-26       Impact factor: 7.094

4.  Murine lupus strains differentially model unique facets of human lupus serology.

Authors:  L Li; S Nukala; Y Du; J Han; K Liu; J Hutcheson; S Pathak; Q Li; C Mohan
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

5.  Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo.

Authors:  Damian Maseda; Susan H Smith; David J DiLillo; Jacquelyn M Bryant; Kathleen M Candando; Casey T Weaver; Thomas F Tedder
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

6.  Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10.

Authors:  Yao Chen; Jinsong Zhang; Kwan-Ki Hwang; Hilary Bouton-Verville; Shi-Mao Xia; Amanda Newman; Ying-Bin Ouyang; Barton F Haynes; Laurent Verkoczy
Journal:  J Immunol       Date:  2013-07-03       Impact factor: 5.422

7.  Activation-induced deaminase contributes to the antibody-independent role of B cells in the development of autoimmunity.

Authors:  Chuancang Jiang; Ming-Lang Zhao; Katherine M Waters; Marilyn Diaz
Journal:  Autoimmunity       Date:  2012-06-25       Impact factor: 2.815

Review 8.  Somatic mutagenesis in autoimmunity.

Authors:  Thiago Detanico; James B St Clair; Katja Aviszus; Greg Kirchenbaum; Wenzhong Guo; Lawrence J Wysocki
Journal:  Autoimmunity       Date:  2013-01-18       Impact factor: 2.815

9.  Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells.

Authors:  Katja Aviszus; Megan K L Macleod; Greg A Kirchenbaum; Thiago O Detanico; Ryan A Heiser; James B St Clair; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

10.  Altered pattern of immunoglobulin hypermutation in mice deficient in Slip-GC protein.

Authors:  Kathleen Richter; Lauranell Burch; Frank Chao; David Henke; Chuancang Jiang; Janssen Daly; Ming-Lang Zhao; Grace Kissling; Marilyn Diaz
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.